For J&J, India may come across as lucrative mkt – ET HealthWorld

REUTERS/Vincent West/File Photo Sources said Biological E can start local manufacturing and supply of J&J’s vaccine in India only if the American firm agrees to follow the legal compensation norms of the country. Considering that J&J is only third to Pfizer and Moderna’s vaccines in America, India may come across as a lucrative market with Biological E as a local partner. The fact that India too is looking at ramping up its vaccination coverage may also make it more viable for J&J. There is an in-principle visibility of around 5…

Read More